Cargando…
L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats
Introduction. Malate is a standard component in fluid therapy within a wide range of medical applications. To date, there are insufficient data regarding its plasma distribution, renal excretion, and metabolism after infusion. This study aimed to investigate these three aspects in a rat model of mod...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925959/ https://www.ncbi.nlm.nih.gov/pubmed/27403429 http://dx.doi.org/10.1155/2016/5237148 |
_version_ | 1782440016786489344 |
---|---|
author | Waack, Indra N. Himmen, Stephan Mueller, Friederike Rohrig, Ricarda Roehrborn, Friederike Teloh, Johanna K. de Groot, Herbert |
author_facet | Waack, Indra N. Himmen, Stephan Mueller, Friederike Rohrig, Ricarda Roehrborn, Friederike Teloh, Johanna K. de Groot, Herbert |
author_sort | Waack, Indra N. |
collection | PubMed |
description | Introduction. Malate is a standard component in fluid therapy within a wide range of medical applications. To date, there are insufficient data regarding its plasma distribution, renal excretion, and metabolism after infusion. This study aimed to investigate these three aspects in a rat model of moderate and severe hemorrhagic shock (HS). Methods. Male Wistar rats were subjected to HS by dropping the mean arterial blood pressure to 25–30 mmHg (severe) and 40–45 mmHg (moderate), respectively, for 60 minutes. Subsequently, reperfusion with Ringer-saline or a malate containing crystalloid solution (7 mM, 13.6 mM, and 21 mM, resp.) was performed within 30 minutes, followed by an observation period of 150 minutes. Results. In the present experiments, malate rapidly disappeared from the blood, while only 5% of the infused malate was renally excreted. In the resuscitation interval the urinary citrate and succinate amounts significantly increased compared to control. Conclusion. Malate's half-life is between 30 and 60 minutes in both, moderate and severe HS. Thus, even under traumatic conditions malate seems to be subjected to rapid metabolism with participation of the kidneys. |
format | Online Article Text |
id | pubmed-4925959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-49259592016-07-11 L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats Waack, Indra N. Himmen, Stephan Mueller, Friederike Rohrig, Ricarda Roehrborn, Friederike Teloh, Johanna K. de Groot, Herbert Biomed Res Int Research Article Introduction. Malate is a standard component in fluid therapy within a wide range of medical applications. To date, there are insufficient data regarding its plasma distribution, renal excretion, and metabolism after infusion. This study aimed to investigate these three aspects in a rat model of moderate and severe hemorrhagic shock (HS). Methods. Male Wistar rats were subjected to HS by dropping the mean arterial blood pressure to 25–30 mmHg (severe) and 40–45 mmHg (moderate), respectively, for 60 minutes. Subsequently, reperfusion with Ringer-saline or a malate containing crystalloid solution (7 mM, 13.6 mM, and 21 mM, resp.) was performed within 30 minutes, followed by an observation period of 150 minutes. Results. In the present experiments, malate rapidly disappeared from the blood, while only 5% of the infused malate was renally excreted. In the resuscitation interval the urinary citrate and succinate amounts significantly increased compared to control. Conclusion. Malate's half-life is between 30 and 60 minutes in both, moderate and severe HS. Thus, even under traumatic conditions malate seems to be subjected to rapid metabolism with participation of the kidneys. Hindawi Publishing Corporation 2016 2016-06-15 /pmc/articles/PMC4925959/ /pubmed/27403429 http://dx.doi.org/10.1155/2016/5237148 Text en Copyright © 2016 Indra N. Waack et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Waack, Indra N. Himmen, Stephan Mueller, Friederike Rohrig, Ricarda Roehrborn, Friederike Teloh, Johanna K. de Groot, Herbert L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title | L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title_full | L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title_fullStr | L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title_full_unstemmed | L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title_short | L-Malate's Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats |
title_sort | l-malate's plasma and excretion profile in the treatment of moderate and severe hemorrhagic shock in rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925959/ https://www.ncbi.nlm.nih.gov/pubmed/27403429 http://dx.doi.org/10.1155/2016/5237148 |
work_keys_str_mv | AT waackindran lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT himmenstephan lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT muellerfriederike lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT rohrigricarda lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT roehrbornfriederike lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT telohjohannak lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats AT degrootherbert lmalatesplasmaandexcretionprofileinthetreatmentofmoderateandseverehemorrhagicshockinrats |